Compare ORIC & ASIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIC | ASIC |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2020 | 2025 |
| Metric | ORIC | ASIC |
|---|---|---|
| Price | $7.61 | $24.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 5 |
| Target Price | $21.79 | ★ $28.40 |
| AVG Volume (30 Days) | ★ 1.8M | 73.7K |
| Earning Date | 11-16-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.67 | ★ 23.44 |
| EPS | N/A | ★ 1.47 |
| Revenue | N/A | ★ $424,339,000.00 |
| Revenue This Year | N/A | $24.89 |
| Revenue Next Year | N/A | $22.34 |
| P/E Ratio | ★ N/A | $16.69 |
| Revenue Growth | N/A | ★ 23.41 |
| 52 Week Low | $7.23 | $16.73 |
| 52 Week High | $14.68 | $29.00 |
| Indicator | ORIC | ASIC |
|---|---|---|
| Relative Strength Index (RSI) | 30.56 | 45.26 |
| Support Level | $7.40 | $23.36 |
| Resistance Level | $14.23 | $25.62 |
| Average True Range (ATR) | 0.70 | 0.84 |
| MACD | -0.10 | 0.08 |
| Stochastic Oscillator | 1.97 | 62.35 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.